Perelman School Of Medicine University Of Pennsylvania

As medicine as a whole reexamines the racism – implicit and explicit – within the structure of treatment and the health care system, the resulting disparities exist as focal points for all specialties, lung cancer not withstanding.

While COVID-19 launched cytokine storm syndrome to the forefront of medical research, there is still much to be learned about these hyperactive immune events, according to a presenter at the Biologic Therapies Summit.

For patients with osteoarthritis associated with Legg-Calvé-Perthes disease, total hip arthroplasty provided excellent improvements in patient-reported outcomes and an acceptable complication rate, according to published results.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about COVID-19 treatment options available to patients with psoriasis.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about COVID-19 vaccination among patients with psoriasis.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, addresses concerns that treatments for psoriatic disease could increase patients’ risk for COVID-19 infection or severe illness.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, discussed results from a recent study evaluating bimekizumab in patients with psoriasis.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, discussed phase 2b data on roflumilast foam presented at AAD VMX 2021.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about research on deucravacitinib presented at AAD VMX 2021.

In a new study, removing “race correction” from the interpretation of pulmonary function test results signaled more prevalent and severe lung disease in Black patients.